Literature DB >> 7165327

Steroid hormone receptors in human melanoma.

H J Grill, P Benes, B Manz, P Schramm, B Morsches, G W Korting, K Pollow.   

Abstract

Human melanomas were investigated for the presence of high-affinity estrogen-, gestagen-, and glucocorticoid-binding proteins. A statistically significant difference was found for mean estrogen receptor (ER) concentrations in melanomas of male versus female origin: female origin 37.6 (0-107) fmol/mg protein, male origin 3.9 (0-8.3) fmol/mg protein. No significant difference between sexes was found for gestragen receptors: 41.5 (0-194) fmol/mg protein for melanomas of female origin versus 99 (0-362) fmol/mg protein for male. Sucrose density gradient analyses revealed specific binding for both receptor types in the 4-5 S region as well as in the 8 S region. The binding affinities were in the same order of magnitude as reported for receptors found in typical steroid target organs. No significant difference in receptor values depending on sex was found for the glucocorticoid receptor: 19.2 (0-43) fmol/mg protein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7165327     DOI: 10.1007/bf00510399

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

1.  A simple ultraviolet spectrophotometric method for the determination of protein.

Authors:  W J WADDELL
Journal:  J Lab Clin Med       Date:  1956-08

2.  Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans.

Authors:  J L Wittliff; R Hilf; W F Brooks; E D Savlov; T C Hall; R A Orlando
Journal:  Cancer Res       Date:  1972-09       Impact factor: 12.701

3.  Endocrine influences on survival from malignant melanoma.

Authors:  H M Shaw; G W Milton; G Farago; W H McCarthy
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

Review 4.  Steroid hormone receptors and melanoma.

Authors:  J P Neifeld; M E Lippman
Journal:  J Invest Dermatol       Date:  1980-06       Impact factor: 8.551

5.  Tamoxifen in malignant melanoma.

Authors:  R A Nesbit; R L Woods; M H Tattersall; R M Fox; J F Forbes; I R MacKay; M Goodyear
Journal:  N Engl J Med       Date:  1979-11-29       Impact factor: 91.245

6.  Tamoxifen in metastatic malignant melanoma.

Authors:  F L Meyskens; J B Voakes
Journal:  Cancer Treat Rep       Date:  1980-01

7.  Oestrogen receptors in human malignant melanoma.

Authors:  R I Fisher; J P Neifeld; M E Lippman
Journal:  Lancet       Date:  1976-08-14       Impact factor: 79.321

  7 in total
  5 in total

Review 1.  Skin steroidogenesis in health and disease.

Authors:  Georgios Nikolakis; Constantine A Stratakis; Theodora Kanaki; Andrej Slominski; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

2.  The effect of estradiol on the sebaceous gland of the hamster ear and its antagonism by tamoxifen.

Authors:  G Schäfer; W Krause
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Progesterone and Estrogen Receptors in Neurofibromas of Patients with NF1.

Authors:  Mauro Geller; Spyros G E Mezitis; Fabio Pereira Nunes; Marcia G Ribeiro; Alexandra Prufer de Q C Araújo; Marcello D Bronstein; Rodrigo Siqueira-Batista; Andréia Patrícia Gomes; Lisa Oliveira; Karin Soares Gonçalves Cunha
Journal:  Clin Med Pathol       Date:  2008-09-15

Review 4.  Is oestrogen an important player in melanoma progression?

Authors:  Marcelina E Janik; Klaudyna Bełkot; Małgorzata Przybyło
Journal:  Contemp Oncol (Pozn)       Date:  2014-11-05

5.  Medium Sized Congenital Melanocytic Nevus with Suspected Progression to Melanoma during Pregnancy: What's the Best for the Patient?

Authors:  Georgi Tchernev; Gabriela Atanasova Dzhelyatova; Uwe Wollina; Ilia Lozev; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.